Evidence map›Paper›PMID 37484098›Full record

ArticleFrontiers in psychology2023

Alzheimer's disease: a continuum with visual involvements.

Lorena Elvira-Hurtado, Inés López-Cuenca, Rosa de Hoz, Mario Salas, Lidia Sánchez-Puebla, Federico Ramírez-Toraño, José A Matamoros, José A Fernández-Albarral, Pilar Rojas, Soraya Alfonsín and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Lorena Elvira-HurtadoRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Inés López-CuencaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Rosa de HozRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Mario SalasMemory Unit, Geriatrics Service, Hospital Clínico San Carlos, Madrid, Spain.
Lidia Sánchez-PueblaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Federico Ramírez-TorañoCenter for Cognitive and Computational Neuroscience, Laboratory of Cognitive and Computational Neuroscience, Complutense University of Madrid, Pozuelo de Alarcón, Spain.
José A MatamorosRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
José A Fernández-AlbarralRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Pilar RojasRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Soraya AlfonsínCenter for Cognitive and Computational Neuroscience, Laboratory of Cognitive and Computational Neuroscience, Complutense University of Madrid, Pozuelo de Alarcón, Spain.
María Luisa Delgado-LosadaHealth Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Ana I RamírezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Juan J SalazarRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Fernando MaestuHealth Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Pedro GilMemory Unit, Geriatrics Service, Hospital Clínico San Carlos, Madrid, Spain.
José M RamírezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Elena Salobrar-GarcíaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain.
Universidad Complutense de Madrid · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESHospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease (AD) is the most common form of dementia affecting the central nervous system, and alteration of several visual structures has been reported. Structural retinal changes are usually accompanied by changes in visual function in this disease. The aim of this study was to analyse the differences in visual function at different stages of the pathology (family history group (FH+), mild cognitive impairment (MCI), mild AD and moderate AD) in comparison with a control group of subjects with no cognitive decline and no family history of AD. Methods: We included 53 controls, 13 subjects with FH+, 23 patients with MCI, 25 patients with mild AD and, 21 patients with moderate AD. All were ophthalmologically healthy. Visual acuity (VA), contrast sensitivity (CS), colour perception, visual integration, and fundus examination were performed. Results: The analysis showed a statistically significant decrease in VA, CS and visual integration score between the MCI, mild AD and moderate AD groups compared to the control group. In the CS higher frequencies and in the colour perception test (total errors number), statistically significant differences were also observed in the MCI, mild AD and moderate AD groups with respect to the FH+ group and also between the control and AD groups. The FH+ group showed no statistically significant difference in visual functions compared to the control group. All the test correlated with the Mini Mental State Examination score and showed good predictive value when memory decline was present, with better values when AD was at a more advanced stage. Conclusion: Alterations in visual function appear in subjects with MCI and evolve when AD is established, being stable in the initial stages of the disease (mild AD and moderate AD). Therefore, visual psychophysical tests are a useful, simple and complementary tool to neuropsychological tests to facilitate diagnosis in the preclinical and early stages of AD.

Indexed as

Alzheimer’s diseasecontrast sensitivityfamily historymild cognitive impairmentPDTvisual acuityvisual function

Identifiers

PMID37484098
PMCPMC10359162
OpenAlexW4383313995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.